This is the authors' abstract. We don't add key points for this paper.
Post-Transplant Lymphoproliferative Disease (PTLD) is defined as a malignancy that occurs post solid organ transplant (SOT). The incidence of PTLD in kidney transplant is lowest amongst all SOT with a majority having a monomorphic pattern that is commonly B cell driven. Plasmacytic variants of PTLD have been rarely reported, with only a handful of cases being clonal in nature. Here we report a unique case of a plasmacytoma-like PTLD with IgG-K restriction confined entirely to the kidney allograft, without evidence of any clonal plasma cell in the bone marrow or other extramedullary site. This case highlights an extremely rare disease, describes a diagnostic dilemma, reports the unconventional management, and poses more interesting questions about the pathophysiology of this disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chowdhury et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: